Got a new idea?   |   PMR Publications   |   PMR Consulting   |   PMR Research   |   PMR Online Access
Business market in Central and Eastern Europe, up-to-date news, analyses and market data.
 
 

Dominacja leków generycznych na rynku farmaceutycznym Europy Środkowo-Wschodniej będzie kontynuowana - listopad 2009

Rynek farmaceutyczny Europy Środkowo-Wschodnie zdominowany jest przez leki generyczne. Ten segment był wart w 2008 r. 17,2 mld euro, a w latach 2009-2011 będzie rozwijał się w tempie około 14% rocznie. Tempo wzrostu leków innowacyjnych, których rynek był wart 12,4 mld zł w 2008 r. będzie niższe, wynika z najnowszego raportu firmy badawczej PMR pt. „Generic and innovative drugs market in Central and Eastern Europe 2009. Comparative analysis, reimbursement policies and development forecasts for 2009-2011”.

To open the FULL free article/document, please sign up.

*required

*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:
Help us better answer your needs.
Why do you sign up?
Please specify:

Privacy Policy


 
People who downloaded this free article, have read also:
 
About us         Contact us         Privacy Policy
Copyright © 2012 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). With over fourteen years of experience, high international standards in projects and publications, highly skilled multilingual staff and a wide network of co-operating research companies and market experts, PMR is one of the largest companies of its type in the region.